CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (919) 636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,310,718
- in 4 filings, $1.2M under 10b5-1 plans
Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-31 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,703 | 248,558 | ||
| 2026-10-12 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +3,846 | $5.53 | $21K | 246,855 |
| 2026-09-30 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,703 | 243,009 | ||
| 2026-08-31 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,703 | 241,306 | ||
| 2026-08-28 | Andrade Robert CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +21,928 | $5.10 | $112K | 239,603 |
| 2026-08-28 | Andrade Robert CHIEF FINANCIAL OFFICER | Option exercise · Stock Options 10b5-1 | −21,928 | 779,330 | ||
| 2026-08-27 | Andrade Robert CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −75,000 | $11.78 | $884K | 217,675 |
| 2026-07-31 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,703 | 292,675 | ||
| 2026-06-30 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,703 | 290,972 | ||
| 2026-05-31 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,703 | 289,269 | ||
| 2026-04-30 | Andrade Robert CHIEF FINANCIAL OFFICER | Option exercise | +1,703 | 287,566 | ||
| 2026-03-31 | Andrade Robert CHIEF FINANCIAL OFFICER | Option exercise | +14,724 | 271,380 | ||
| 2026-03-31 | Andrade Robert CHIEF FINANCIAL OFFICER | Option exercise | +2,213 | 273,593 | ||
| 2026-03-31 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award · Stock Options | +120,000 | $5.77 | $692K | 921,045 |
| 2026-03-28 | Andrade Robert CHIEF FINANCIAL OFFICER | Option exercise | +12,270 | 285,863 | ||
| 2026-03-26 | Andrade Robert CHIEF FINANCIAL OFFICER | Option exercise | +13,072 | $5.10 | $67K | 256,656 |
| 2026-03-26 | Andrade Robert CHIEF FINANCIAL OFFICER | Option exercise · Stock Options | −13,072 | $5.10 | $67K | 801,045 |
| 2026-02-28 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,191 | 243,584 | ||
| 2026-02-18 | Andrade Robert CHIEF FINANCIAL OFFICER | Option exercise | +2,450 | $4.08 | $10K | 215,108 |
| 2026-02-18 | Andrade Robert CHIEF FINANCIAL OFFICER | Option exercise | +27,285 | 242,393 |
Page 1 of 2 · 35 trades